№1
Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems*
Richard M. Bergenstal, Adam Heller, Marc D. Breton, RobertVigersky, Susan A. Brown, Gregory P. Forlenza, Jennifer L. Sherr, Roman Hovorka, Steven J. Russell, Edward R.Damiano, Melissa S. Putman, Roy W. Beck, Eric Renard, Rayhan Lal, Claudio Cobelli, Eyal Dassau, Halis K. Akturk, Michael A. Weiss, Jay S. Skyler
8-21
№2
Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2
Lim CE., Pasternak B., Eliasson B. et al.
22-40
№3
Risk factors for heart failure in patients with type 2 diabetes mellitus
Zubovych I.V. , Mankovsky B.M.
41-47
№4
Engaging with patients in humanitarian crises: learning from access to insulin in Ukraine
Iryna Vlasenko, Sylvia Kehlenbrink
48-50
№5
51-54
№6
GRAND ROUND 2025:
Clinical Navigator in Endocrinology
Workshop “Infection Control”:
Safety as a Component of Quality Medical Care
56-57
№7
Five positive effects of art on mental health
DOI: https://doi.org/10.57105/2415-7252-2024-2-03
66-68